Wednesday, April 26, 2017
11:00 am lecture; 12:00 noon reception
Prem Sahai Auditorium, 1110 MERF
(this event is free and open to the public)
The Joe L. Parkin Memorial Lecture on Aging
"A Short-Lived Fish as a New Model for Aging"
Christoph Englert, PhD
Professor of Molecular Genetics
Leibniz Institute on Aging
Fritz Lipmann Institute and Friedrich-Schiller University
Christoph Englert studied Biochemistry in Tübingen and Munich. Having received his PhD from the Max Planck Institute for Biochemistry / University of Munich in 1992, he carried out his postdoctoral training with Daniel Haber at the Cancer Center of Massachusetts General Hospital / Harvard Medical School. Returning to Germany, Christoph became a junior group leader in Karlsruhe in 1996 and in 2002 became an Associate Professor of Physiological Chemistry at the University of Würzburg. Since 2004 he has been a Full Professor at the University of Jena and is also a senior group leader at the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI).
Research in the Englert lab focuses on the relationship between the development of an organism and disease. Expanding this topic, he, together with a colleague, has established and developed a short-lived African killifish, Nothobranchius furzeri, as a new model for age research. This provided the opportunity to combine his experience and interest in questions of developmental genetics with relevant questions of age research. Currently, a number of projects in his lab utilize N. furzeri, allowing the investigation of the age-dependency of organ homeostasis and regeneration as well as the genetic basis of aging. Work on Nothobranchius at FLI has recently culminated in the high-ranking publication of its genome, which provided a number of novel insights into the biology of aging.
Tuesday, October 4, 2016
Honoring Health Care Preferences through Caring Conversations
Professional Conference: 8:00 am - 12:00 pm
The Conversation: A Revolutionary Plan for End-of-Life Care
A community-wide presentation: 6:30 pm - 7:30 pm
A key ingredient to informed patient-doctor discussions regarding end-of-life care includes the patient's ability to understand and imagine hypothetical disease states and medical interventions. However, studies suggest that there are numerous barriers to communication between doctors and patients. One innovation to surmount these barriers includes using video decision aids to reinforce end-of-life conversations. Dr. Angelo E. Volandes leads a group of internationally recognized researchers who create and study video decision aids to empower patients and families to make informed decisions at the end of life.
Dr. Volandes is a faculty member in the General Medicine Unit at the Massachusetts General Hospital and Assistant Professor of Medicine at Harvard Medical School. Dr. Volandes' research is focused on improving decision-making at the end of life and is supported by the NIH, the Agency for Healthcare Research and Quality, the Alzheimer's Association and the informed Medical Decisions Foundation.
He received his BA in philosophy from Harvard College, his medical degree from the Yale School of Medicine, and a Masters of Public Health from the Harvard School of Public Health. Following medical school, Dr. Volandes completed a residency in internal medicine at the University of Pennsylvania. He then completed fellowships in medical ethics at Harvard Medical School and Brigham and Women's Hospital. He was named the Edmond J. Safra Faculty Fellow in 2004-05 at the Harvard University Center for Ethics.
His first book was released in 2015 by Bloomsbury Press and is titled, "The Conversation: A Revolutionary Plan for End-of-Life Care."